
Panelast; L&R, Rengsdorf, Germany); and group 3,
compression stockings and an eccentric pad on the
thigh GSV site. All devices were worn for 7 days. Outcomes included pressures achieved (supine and standing, day 1 and day 7), major adverse events at day 7
(VAS pain score >6, extensive hematoma, bleeding
through bandage, superï¬cial venous thrombosis, or
DVT